IMBA-Institute of Molecular Biotechnology of the Austrian Academy of Science Vienna 1030, Austria.
Science. 2014 Jul 18;345(6194):1247125. doi: 10.1126/science.1247125. Epub 2014 Jul 17.
Classical experiments performed half a century ago demonstrated the immense self-organizing capacity of vertebrate cells. Even after complete dissociation, cells can reaggregate and reconstruct the original architecture of an organ. More recently, this outstanding feature was used to rebuild organ parts or even complete organs from tissue or embryonic stem cells. Such stem cell-derived three-dimensional cultures are called organoids. Because organoids can be grown from human stem cells and from patient-derived induced pluripotent stem cells, they have the potential to model human development and disease. Furthermore, they have potential for drug testing and even future organ replacement strategies. Here, we summarize this rapidly evolving field and outline the potential of organoid technology for future biomedical research.
半个世纪前进行的经典实验证明了脊椎动物细胞具有巨大的自我组织能力。即使完全解离,细胞也可以重新聚集并重建器官的原始结构。最近,这一突出的特性被用于从组织或胚胎干细胞中重建器官部分甚至完整器官。这种由干细胞衍生的三维培养物称为类器官。由于类器官可以从人类干细胞和患者来源的诱导多能干细胞中生长,因此它们有可能模拟人类的发育和疾病。此外,它们具有药物测试甚至未来器官替代策略的潜力。在这里,我们总结了这一快速发展的领域,并概述了类器官技术在未来生物医学研究中的潜力。